Table of Contents Author Guidelines Submit a Manuscript
Canadian Journal of Infectious Diseases and Medical Microbiology
Volume 2016 (2016), Article ID 2782786, 9 pages
http://dx.doi.org/10.1155/2016/2782786
Research Article

HIV Prophylaxis in High Risk Newborns: An Examination of Sociodemographic Factors in an Inner City Context

1St. Michael’s Hospital, University of Toronto, Toronto, ON, Canada M5B 1W8
2Department of Pediatrics, Hospital for Sick Children, Toronto, ON, Canada M5G 1X8
3Department of Medicine, University of Toronto, Toronto, ON, Canada M5S 1A8
4Dalla Lana School of Public Health, University of Toronto, Toronto, ON, Canada M5T 3M7
5Keenan Research Centre of the Li Ka Shing Knowledge Institute, St. Michael’s Hospital, Toronto, ON, Canada M5B 1T8

Received 13 March 2015; Accepted 23 September 2015

Copyright © 2016 Zenita Alidina et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. C. Forbes, A. M. Alimenti, J. Singer et al., “A national review of vertical HIV transmission,” AIDS, vol. 26, no. 6, pp. 757–763, 2012. View at Publisher · View at Google Scholar · View at Scopus
  2. J. Warszawski, R. Tubiana, J. Le Chenadec et al., “Mother-to-child HIV transmission despite antiretroviral therapy in the ANRS French Perinatal Cohort,” AIDS, vol. 22, no. 2, pp. 289–299, 2008. View at Publisher · View at Google Scholar · View at Scopus
  3. HIV/AIDS Surveillance Reports, “At a glance,” in HIV and AIDS in Canada: Surveillance Report to December 31st, 2013, Public Health Agency of Canada, 2013. View at Google Scholar
  4. R. S. Remis and J. Liu, HIV/AIDS in Ontario: Preliminary Report, 2011, Ontario Ministry of Health and Long-Term Care, 2013.
  5. E. M. Connor, R. S. Sperling, R. Gelber et al., “Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. Pediatric AIDS Clinical Trials Group Protocol 076 Study Group,” The New England Journal of Medicine, vol. 331, no. 18, pp. 1173–1180, 1994. View at Publisher · View at Google Scholar · View at Scopus
  6. K. Nielsen-Saines, D. H. Watts, V. G. Veloso et al., “Three postpartum antiretroviral regimens to prevent intrapartum HIV infection,” The New England Journal of Medicine, vol. 366, no. 25, pp. 2368–2379, 2012. View at Publisher · View at Google Scholar · View at Scopus
  7. B. Buchholz, M. Beichert, U. Marcus et al., “German-Austrian recommendations for HIV1-therapy in pregnancy and in HIV1-exposed newborn, update 2008,” European Journal of Medical Research, vol. 14, no. 11, pp. 461–479, 2009. View at Google Scholar · View at Scopus
  8. C. Thorne, S. Fiore, C. Peckham, and M. L. Newell, “Mother-to-child transmission of HIV infection in the era of highly active antiretroviral therapy,” Clinical Infectious Diseases, vol. 40, no. 3, pp. 458–465, 2005. View at Publisher · View at Google Scholar · View at Scopus
  9. E. Paintsil and W. A. Andiman, “Care and management of the infant of the HIV-1-infected mother,” Seminars in Perinatology, vol. 31, no. 2, pp. 112–123, 2007. View at Publisher · View at Google Scholar · View at Scopus
  10. E. R. Cooper, M. Charurat, L. Mofenson et al., “Combination antiretroviral strategies for the treatment of pregnant HIV-1-infected women and prevention of perinatal HIV-1 transmission,” Journal of Acquired Immune Deficiency Syndromes, vol. 29, no. 5, pp. 484–494, 2002. View at Publisher · View at Google Scholar · View at Scopus
  11. Panel on Treatment of HIV-Infected Pregnant Women and Prevention of Perinatal Transmission, “Recommendations for Use of Antiretroviral Drugs in Pregnant HIV-1-Infected Women for Maternal Health and Interventions to Reduce Perinatal HIV Transmission in the United States,” 2014, http://aidsinfo.nih.gov/contentfiles/lvguidelines/PerinatalGL.pdf.
  12. H. Talaie, A. A. Nava-Ocampo, and G. Koren, “Antiretroviral treatment of maternal HIV infection,” Canadian Family Physician, vol. 50, pp. 865–868, 2004. View at Google Scholar · View at Scopus
  13. A. Bitnun, Guidelines for the Prevention of Mother-to-Child HIV Transmission, Hospital for Sick Children, Toronto, Canada, 2012.
  14. A. Bitnun, J. Brophy, L. Samson et al., “Prevention of vertical HIV transmission and management of the HIV-exposed infant in Canada in 2014,” Canadian Journal of Infectious Diseases and Medical Microbiology, vol. 25, no. 2, pp. 75–82, 2014. View at Publisher · View at Google Scholar · View at Scopus
  15. S. Blanche, M. Tardieu, V. Benhammou, J. Warszawski, and P. Rustin, “Mitochondrial dysfunction following perinatal exposure to nucleoside analogues,” AIDS, vol. 20, no. 13, pp. 1685–1690, 2006. View at Publisher · View at Google Scholar · View at Scopus
  16. C. Thorne and M.-L. Newell, “Safety of agents used to prevent mother-to-child transmission of HIV: is there any cause for concern?” Drug Safety, vol. 30, no. 3, pp. 203–213, 2007. View at Publisher · View at Google Scholar · View at Scopus
  17. C. Feiterna-Sperling, K. Weizsaecker, C. Bührer et al., “Hematologic effects of maternal antiretroviral therapy and transmission prophylaxis in HIV-1-exposed uninfected newborn infants,” Journal of Acquired Immune Deficiency Syndromes, vol. 45, no. 1, pp. 43–51, 2007. View at Publisher · View at Google Scholar · View at Scopus
  18. W. Ferguson, M. Goode, A. Walsh, P. Gavin, and K. Butler, “Evaluation of 4 weeks' neonatal antiretroviral prophylaxis as a component of a prevention of mother-to-child transmission program in a resource-rich setting,” Pediatric Infectious Disease Journal, vol. 30, no. 5, pp. 408–412, 2011. View at Publisher · View at Google Scholar · View at Scopus
  19. R. Lahoz, A. Noguera, N. Rovira et al., “Antiretroviral-related hematologic short-term toxicity in healthy infants: implications of the new neonatal 4-week zidovudine regimen,” Pediatric Infectious Disease Journal, vol. 29, no. 4, pp. 376–379, 2010. View at Publisher · View at Google Scholar · View at Scopus
  20. J. Neubert, M. Pfeffer, A. Borkhardt et al., “Risk adapted transmission prophylaxis to prevent vertical HIV-1 transmission: effectiveness and safety of an abbreviated regimen of postnatal oral Zidovudine,” BMC Pregnancy and Childbirth, vol. 13, article 22, 2013. View at Publisher · View at Google Scholar · View at Scopus
  21. B. M. Branson, H. H. Handsfield, M. A. Lampe et al., “Revised recommendations for HIV testing of adults, adolescents, and pregnant women in health-care settings,” Morbidity and Mortality Weekly Report, vol. 55, no. 14, pp. 1–17, 2006. View at Google Scholar
  22. “HIV testing and prophylaxis to prevent mother-to-child transmission in the united states,” Pediatrics, vol. 122, no. 5, pp. 1127–1134, 2008. View at Publisher · View at Google Scholar · View at Scopus
  23. B. W. C. Forsyth, S. R. Barringer, T. A. Walls et al., “Rapid HIV testing of women in labor: too long a delay,” Journal of Acquired Immune Deficiency Syndromes, vol. 35, no. 2, pp. 151–154, 2004. View at Publisher · View at Google Scholar · View at Scopus
  24. N. A. Wade, G. S. Birkhead, B. L. Warren et al., “Abbreviated regimens of zidovudine prophylaxis and perinatal transmission of the human immunodeficiency virus,” New England Journal of Medicine, vol. 339, no. 20, pp. 1409–1414, 1998. View at Publisher · View at Google Scholar · View at Scopus
  25. A. E. Singh, B. Lee, J. Fenton, and J. Preiksaitis, “The INSTI HIV-1/HIV-2 antibody test: a review,” Expert Opinion on Medical Diagnostics, vol. 7, no. 3, pp. 299–308, 2013. View at Publisher · View at Google Scholar · View at Scopus